FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

424919009: Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug)


    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    3679328019 Product containing precisely glimepiride 4 milligram and pioglitazone hydrochloride 30 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3679329010 Glimepiride 4 mg and pioglitazone hydrochloride 30 mg oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    4723451000005114 glimepirid 4 mg + pioglitazon 30 mg tablet da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


    0 descendants.

    Expanded Value Set


    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    glimepirid 4 mg + pioglitazon 30 mg tablet Is a Product containing glimepiride and pioglitazone (medicinal product) false Inferred relationship Some
    glimepirid 4 mg + pioglitazon 30 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glimepiride (substance) false Inferred relationship Some
    glimepirid 4 mg + pioglitazon 30 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Thiazolidinedione (substance) false Inferred relationship Some
    glimepirid 4 mg + pioglitazon 30 mg tablet Has manufactured dose form A solid single-dose preparation obtained by compressing uniform volumes of particulate solids or by extrusion or moulding. Tablets may be single layer tablets resulting from a single compression of particles and or multilayer tablets consisting of concentric or parallel layers obtained by successive compressions of particles of different composition. false Inferred relationship Some
    glimepirid 4 mg + pioglitazon 30 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Pioglitazone (substance) false Inferred relationship Some
    glimepirid 4 mg + pioglitazon 30 mg tablet Has manufactured dose form Oral tablet false Inferred relationship Some
    glimepirid 4 mg + pioglitazon 30 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Pioglitazone hydrochloride false Inferred relationship Some
    glimepirid 4 mg + pioglitazon 30 mg tablet Is a Product manufactured as oral dose form (product) false Inferred relationship Some
    glimepirid 4 mg + pioglitazon 30 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Glimepiride (substance) false Inferred relationship Some 1
    glimepirid 4 mg + pioglitazon 30 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Glimepiride (substance) false Inferred relationship Some 1
    glimepirid 4 mg + pioglitazon 30 mg tablet Has presentation strength numerator value fire false Inferred relationship Some 1
    glimepirid 4 mg + pioglitazon 30 mg tablet This attribute specifies the numerator unit for the presentation strength of a product. mg false Inferred relationship Some 1
    glimepirid 4 mg + pioglitazon 30 mg tablet Has presentation strength denominator value en false Inferred relationship Some 1
    glimepirid 4 mg + pioglitazon 30 mg tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) false Inferred relationship Some 1
    glimepirid 4 mg + pioglitazon 30 mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Pioglitazone hydrochloride false Inferred relationship Some 2
    glimepirid 4 mg + pioglitazon 30 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Pioglitazone hydrochloride false Inferred relationship Some 2
    glimepirid 4 mg + pioglitazon 30 mg tablet Has presentation strength numerator value 30 false Inferred relationship Some 2
    glimepirid 4 mg + pioglitazon 30 mg tablet This attribute specifies the numerator unit for the presentation strength of a product. mg false Inferred relationship Some 2
    glimepirid 4 mg + pioglitazon 30 mg tablet Has presentation strength denominator value en false Inferred relationship Some 2
    glimepirid 4 mg + pioglitazon 30 mg tablet This attribute specifies the denominator unit for the presentation strength of a product. Tablet (unit of presentation) false Inferred relationship Some 2
    glimepirid 4 mg + pioglitazon 30 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Pioglitazone hydrochloride false Inferred relationship Some 2
    glimepirid 4 mg + pioglitazon 30 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Glimepiride (substance) false Inferred relationship Some 1
    glimepirid 4 mg + pioglitazon 30 mg tablet Has unit of presentation Tablet (unit of presentation) false Inferred relationship Some
    glimepirid 4 mg + pioglitazon 30 mg tablet Is a Product containing glimepiride and pioglitazone in oral dose form (medicinal product form) false Inferred relationship Some
    glimepirid 4 mg + pioglitazon 30 mg tablet Count of base of active ingredient to false Inferred relationship Some
    glimepirid 4 mg + pioglitazon 30 mg tablet Is a Glimepiride and pioglitazone only product in oral dose form false Inferred relationship Some
    glimepirid 4 mg + pioglitazon 30 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Glimepiride (substance) false Inferred relationship Some 2
    glimepirid 4 mg + pioglitazon 30 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Pioglitazone hydrochloride false Inferred relationship Some 1
    glimepirid 4 mg + pioglitazon 30 mg tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). Pioglitazone hydrochloride false Inferred relationship Some 1
    glimepirid 4 mg + pioglitazon 30 mg tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. Glimepiride (substance) false Inferred relationship Some 2

    Inbound Relationships Type Active Source Characteristic Refinability Group

    Reference Sets

    Concept inactivation indicator reference set

    REPLACED BY association reference set (foundation metadata concept)

    Back to Start